معرفی
Dmitrii Mazurov is a Research Scientist in the Department of Microbial Pathogenesis at Yale School of Medicine, Yale University, specializing in virology, immunology, and CRISPR-based genome editing. His research focuses on developing innovative strategies to combat HIV-1 through T-cell engineering, viral transmission inhibition, and therapeutic antibody design.
Mazurov's work spans molecular biology, virology, and nanotechnology, with emphasis on enhancing CRISPR efficiency for gene knock-in, optimizing antiviral nanoparticles, and elucidating mechanisms of viral resistance. His recent publications (2021–2024) demonstrate expertise in:
- CRISPR/Cas systems for HIV resistance engineering.
- Quantifying viral transmission and antibody evasion in HIV/SARS-CoV-2.
- Designing chimeric antibodies and virus-like particles for therapeutic delivery.
- Regulating immune signaling proteins like CD45 and LPAP.
He conducts research within the Mothes Lab, leveraging interdisciplinary approaches to address challenges in infectious disease therapeutics.
